Dual Action of Eeyarestatin 24 on Sec-Dependent Protein Secretion and Bacterial DNA
ACS Infectious Diseases · 10.02.2023 · 9 (2) · 253-269
DOI: 10.1021/acsinfecdis.2c00404 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 13.01.2023. Verfasst von Ann-Britt Schäfer und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Chemical Biology, Department of Life Sciences, Chalmers University of Technology, 412 96 Gothenburg, Sweden. Hauptthemen laut MEDLINE: Escherichia coli, Anti-Bacterial Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Chalmers Tekniska H?gskola, Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Eeyarestatin 24 (ES24) is a promising new antibiotic with broad-spectrum activity. It shares structural similarity with nitrofurantoin (NFT), yet appears to have a distinct and novel mechanism: ES24 was found to inhibit SecYEG-mediated protein transport and membrane insertion in Gram-negative bacteria. However, possible additional targets have not yet been explored. Moreover, its activity was notably better against Gram-positive bacteria, for which its mechanism of action had not yet been investigated. We have used transcriptomic stress response profiling, phenotypic assays, and protein secretion analyses to investigate the mode of action of ES24 in comparison with NFT using the Gram-positive model bacterium Bacillus subtilis and have compared our findings to Gram-negative Escherichia coli. Here, we show the inhibition of Sec-dependent protein secretion in B. subtilis and additionally provide evidence for DNA damage, probably caused by the generation of reactive derivatives of ES24. Interestingly, ES24 caused a gradual dissipation of the membrane potential, which led to delocalization of cytokinetic proteins and subsequent cell elongation in E. coli. However, none of those effects were observed in B. subtilis, thereby suggesting that ES24 displays distinct mechanistic differences with respect to Gram-positive and Gram-negative bacteria. Despite its structural similarity to NFT, ES24 profoundly differed in our phenotypic analysis, which implies that it does not share the NFT mechanism of generalized macromolecule and structural damage. Importantly, ES24 outperformed NFT in vivo in a zebrafish embryo pneumococcal infection model. Our results suggest that ES24 not only inhibits the Sec translocon, but also targets bacterial DNA and, in Gram-negative bacteria, the cell membrane.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Chemical Biology, Department of Life Sciences, Chalmers University of Technology, 412 96 Gothenburg, Sweden.
- Molecular Microbiology, Amsterdam Institute of Molecular and Life Sciences (AIMMS), Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
- Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers - Location Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands.
- Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, 1081 HZ Amsterdam, The Netherlands.
- Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, PO Box 30001, 9700 RB Groningen, The Netherlands.
- School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, United Kingdom.
ORCID-Profile: Roger C Whitehead, Sven Halbedel, Jan Maarten van Dijl, Michaela Wenzel
Förderung
- Wellcome Trust
- Chalmers Tekniska H?gskola
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zitieren
APA
Schäfer, A. B., Steenhuis, M., Jim, K. K., Neef, J., O'Keefe, S., Whitehead, R. C., Swanton, E., Wang, B., Halbedel, S., High, S., van Dijl, J. M., Luirink, J., & Wenzel, M. (2023). Dual Action of Eeyarestatin 24 on Sec-Dependent Protein Secretion and Bacterial DNA. ACS Infectious Diseases, 9(2), 253-269. https://doi.org/10.1021/acsinfecdis.2c00404
Vancouver
Schäfer AB, Steenhuis M, Jim KK, Neef J, O'Keefe S, Whitehead RC, et al. Dual Action of Eeyarestatin 24 on Sec-Dependent Protein Secretion and Bacterial DNA. ACS Infectious Diseases. 2023;9(2):253-269. doi:10.1021/acsinfecdis.2c00404
BibTeX
@article{Schfer2023,
author = {Schäfer, Ann-Britt and Steenhuis, Maurice and Jim, Kin Ki and Neef, Jolanda and O'Keefe, Sarah and Whitehead, Roger C and Swanton, Eileithyia and Wang, Biwen and Halbedel, Sven and High, Stephen and van Dijl, Jan Maarten and Luirink, Joen and Wenzel, Michaela},
title = {Dual Action of Eeyarestatin 24 on Sec-Dependent Protein Secretion and Bacterial DNA},
journal = {ACS Infectious Diseases},
year = {2023},
volume = {9},
number = {2},
pages = {253--269},
doi = {10.1021/acsinfecdis.2c00404}
}
EUVIMED